SDZ NKT 343
Names
Biological Activity
[Description]:
SDZ NKT 343 is a selective, orally active NK1 receptor antagonist with an IC50 of 0.62 nM against human NK1 receptor. SDZ NKT 343 has good analgesic activity[1][2].
[Related Catalog]:
[Target]
hNK1:0.62 nM (IC50)
hNK2:0.52 μM (Ki)
hNK3:3.4 μM (Ki)
[In Vitro]
SDZ NKT 343 shows a markedly lower affinity at rat NK1 receptors in whole forebrain membranes (IC50=451+139 nM)[1]. SDZ NKT 343 shows weak affinity to human NK2 and NK3 receptors in transfected Cos-7 cells (Ki of 0.52+0.04 μM and 3.4+1.2 μM respectively)[1].
[In Vivo]
SDZ NKT 343 antagonized [Sar9]SP sulphone-evoked bronchoconstriction (70% reduction at 0.4 mg/kg, i.v.) in anaesthetized guinea-pigs[1].
[References]
Chemical & Physical Properties
[ Density]:
1.327g/cm3
[ Boiling Point ]:
892.8ºC at 760mmHg
[ Molecular Formula ]:
C33H33N5O5
[ Molecular Weight ]:
579.64600
[ Flash Point ]:
493.8ºC
[ Exact Mass ]:
579.24800
[ PSA ]:
127.57000
[ LogP ]:
6.05540
[ Vapour Pressure ]:
0mmHg at 25°C
[ Index of Refraction ]:
1.676